The word on the street is that yesterday's Health Research Authority (HRA) public and patient involvement workshop - it's first public flotation if I can put it like that - was very successful indeed. That has to be good news. I think we should be encouraged that the team at HRA has barely got its feet under … Continue reading Health Research Authority (HRA) stocks rise in first public flotation
On my train journey from Edinburgh this morning, I listened to a BBC Radio Scotland phone-in about the implications of Scottish independence. The intricacies of a possible de-coupling from the UK are fascinating - from the economy to people's pensions, to the NHS. I've yet to read an article written specifically about the pros and cons … Continue reading I’ve got a pile of irony to do tonight – from Scottish independence to NHS reform
Over a half a million members of the British public took part in clinical trials through the NIHR Clinical Trials Research Networks in 2010, a 24% increase on the year before. Those are the Government's figures, not mine. Last week's 'life sciences' announcement included a range of measures to increase patient recruitment to trials. These include … Continue reading In defence of the clinical trial patient: a health research ombudsman?
The Health Research Authority (HRA) has published the plan for what it will be up too in the months leading up to March 2012. Really pleased to see a commitment under the Governance section (para 3.3) to develop a comprehensive plan for public and patient involvement. You'll see the statement mentions working with both INVOLVE and AMRC … Continue reading Health Research Authority (HRA) commits to public involvement from day one
Sometimes you are just defeated by the brilliance of others. So, if you are looking for a wonderful summary of what the autumn statement means for health research, then I can highly recommend Becky's Policy Pages. Clearly, the opening up of health data is the single most important strategic announcement in today's statement - much … Continue reading Patients, ethics committees and clinical research – NRES/INVOLVE report highlights ‘public’ challenge for new health research regulator (HRA)